Merrimack Pharma Stock Price (NASDAQ:MACK)

Add to My Stocks
$5.22 $0.08 (1.51%) MACK stock closing price Jul 20, 2018 (Closing)
Prev Close* : $5.3
Market Cap:
$70.72M
Day Low: $5.2
52 Week Low: $4.71
Open: $5.3
Volume: -
Day High: $5.31
52 Week High: $15.40
Dividend:
0.00

Latest Stock Market News

Latest Articles

Merrimack Pharma News - From Partners

MACK Stockcharts

View MACK PE ratio, PS ratio stocks charts and compare with peers.
MACK Chart
Note: Compare Merrimack Pharma stock price history with the index and industry peers.

Merrimack Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Merrimack Pharma Returns

ROE
(return on equity)
2057%

Merrimack Pharma Financial Ratios

Asset Turnover
0
Receivables Turnover
0
Debt to Equity
0
Dividend Yield
-999.0000

MACK Industry Peers

Company Price Change (%)
Applied Genetic Technologies (AGTC)4.050.1 (2.41%)
Histogenics (HSGX)2.370.06 (2.47%)
Immune Pharma (IMNP)0.190 (0%)
Fibrogen (FGEN)65.050.65 (1.01%)
Cascade Corp (CASC)10.020 (0%)
Macrogenics (MGNX)22.270.04 (0.18%)
Aveo Pharmaceuticals (AVEO)2.140.04 (1.83%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
GTx (GTXI)16.811.46 (9.51%)
Mirati Therapeutics (MRTX)55.054.05 (7.94%)
AVID BIOSERVICS (CDMO)6.070.4 (7.05%)
NewLink Genetics (NLNK)4.670.11 (2.41%)
Verastem (VSTM)8.310.18 (2.21%)
Revance (RVNC)29.4250.57 (1.98%)
Paratek Pharma (PRTK)10.60.2 (1.92%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 21, 2018
CompanyPriceChange (%)
Sorrento Therapeutics (SRNE)6.1250.68 (10%)
MiMedx (MDXG)3.740.28 (6.97%)
ELOXX PHARMACT (ELOX)16.231.06 (6.13%)
Agenus (AGEN)2.120.12 (5.36%)
Catalyst Biosciences (CBIO)10.380.53 (4.86%)
MediciNova (MNOV)8.530.4 (4.48%)
Uniquire (QURE)34.091.51 (4.24%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 21, 2018

Merrimack Pharmaceuticals Inc Stock News - Partner Headlines

Merrimack Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-144.27M89.25M102.75M47.78M
Net Income472.02M-151.74M-147.95M-83.29M-130.92M
Total Operating Expense95.76M247.49M218.77M169M168.31M
View Merrimack Pharma income statement
balance sheet20172016201520142013
Total Assets117.32M81.48M234.88M158.65M192.41M
Total Liabilities21.04M332.6M418.8M260.79M235.88M
Shareholders Equity96.28M-251.12M-183.92M-102.14M-43.46M
View Merrimack Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-19.6M-62.06M14.57M23.1M14.98M
Net Cash from (used by) Operating Activities-145.93M-170.24M-105.35M-34.8M-95.17M
Increase (Decrease) in Prop Plant And Equipment--3.15M-12.78M-6.03M-9.85M
View Merrimack Pharma cash flow statement

Merrimack Pharma Stock Message Board

Merrimack Pharma stock lost 1.51%, and the last close price as of Jul 20, 2018 is $5.22 for MACK stock. The total market value as denoted by $70.72M for Merrimack Pharma, is the market value of the company's outstanding shares. Merrimack Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Merrimack Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Merrimack Pharma stock quote data shows the number of shares traded. For Ex: 56,443 Merrimack Pharma shares were traded as of last trading day, as seen from Merrimack Pharma stock chart. Merrimack Pharma paid 0.00 stock dividends to its shareholders during last quarter. Merrimack Pharma stock price history, gives the entire historical data for MACK stock.